Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
Status:
Completed
Trial end date:
2020-11-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravenous azithromycin is effective in
eradicating Ureaplasma respiratory tract infection in preterm infants born at 24 to 28 weeks
gestation.
Phase:
Phase 2
Details
Lead Sponsor:
Rose Viscardi University of Maryland, Baltimore
Collaborators:
Christiana Care Health Services Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Johns Hopkins University Mercy Medical Center University of Alabama at Birmingham University of Virginia